{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:50:13Z","timestamp":1790949013979,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.suronc.2023.102014","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T16:00:52Z","timestamp":1699027252000},"page":"102014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Femoral metastatic pathological fractures, impending and actual fractures \u2013 A patient survival study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-9152","authenticated-orcid":false,"given":"Oded","family":"Hershkovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojahed","family":"Sakhnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Barkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2023.102014_bib1","first-page":"1503","article-title":"Surgical management of metastatic bone disease","volume":"91","author":"Bickels","year":"2009"},{"key":"10.1016\/j.suronc.2023.102014_bib2","first-page":"22","article-title":"Metastatic disease around the hip: maintaining quality of life","volume":"94","author":"Haidukewych G.J.T.J.o.B.","year":"2012"},{"key":"10.1016\/j.suronc.2023.102014_bib3","first-page":"256","article-title":"Metastatic disease in long bones A proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels","year":"1989"},{"key":"10.1016\/j.suronc.2023.102014_bib4","first-page":"S77","article-title":"Treatment of pathologic fractures of the proximal femur","volume":"49","author":"Angelini","year":"2018"},{"key":"10.1016\/j.suronc.2023.102014_bib5","doi-asserted-by":"crossref","unstructured":"Mavrogenis, A.F., Pala, E., Romagnoli, C., Romantini, M., Calabro, T., & Ruggieri, P. (2012). Survival analysis of patients with femoral metastases. J. Surg. Oncol., 105(2), 135-141.","DOI":"10.1002\/jso.22061"},{"key":"10.1016\/j.suronc.2023.102014_bib6","article-title":"Percutaneous fixation of impending fracture of the hip","volume":"25","author":"Roux","year":"2022"},{"key":"10.1016\/j.suronc.2023.102014_bib7","first-page":"1175","article-title":"Fracture risk assessment and clinical decision making for patients with metastatic bone disease","volume":"38","author":"Damron","year":"2020"},{"key":"10.1016\/j.suronc.2023.102014_bib8","first-page":"118","article-title":"Current surgical management of bone metastases in the extremities and pelvis","volume":"Vol. 35","author":"Ogilvie","year":"2008"},{"key":"10.1016\/j.suronc.2023.102014_bib9","first-page":"2091","article-title":"Surgical management of metastatic disease of the proximal part of the femur","volume":"96","author":"Issack","year":"2014"},{"key":"10.1016\/j.suronc.2023.102014_bib10","series-title":"Research, R. Treatment of Manifest and Impending Pathologic Fractures of the Femoral Neck by Cemented Hemiarthroplasty","first-page":"220","author":"Ih","year":"1990"},{"key":"10.1016\/j.suronc.2023.102014_bib11","series-title":"Research, R. Metastatic Bone Disease. A Study of the Surgical Treatment of 166 Pathologic Humeral and Femoral Fractures","first-page":"213","author":"Yazawa","year":"1990"},{"key":"10.1016\/j.suronc.2023.102014_bib12","first-page":"3354","article-title":"Treatment modalities for pathologic fractures of the proximal femur pertrochanteric region: a systematic review and meta-analysis of reoperation Rates","volume":"33","author":"Putnam","year":"2018"},{"key":"10.1016\/j.suronc.2023.102014_bib13","first-page":"922","article-title":"Length of stay, mortality, morbidity and delay to surgery in hip fractures","volume":"91","author":"Lefaivre","year":"2009"},{"key":"10.1016\/j.suronc.2023.102014_bib14","first-page":"163","article-title":"Prognostic factors and predictive model for in-hospital mortality following hip fractures in the elderly","volume":"21","author":"Sanz-Reig","year":"2018"},{"key":"10.1016\/j.suronc.2023.102014_bib15","first-page":"201","article-title":"The biology of aging and cancer: frailty, inflammation, and immunity","volume":"23","author":"Zhang","year":"2017"},{"key":"10.1016\/j.suronc.2023.102014_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.14336\/AD.2017.0103","article-title":"The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks","volume":"8","author":"Aunan","year":"2017","journal-title":"Aging Dis"},{"key":"10.1016\/j.suronc.2023.102014_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2021.02.004","article-title":"Risks and complications after arthroplasty for pathological or impending pathological fracture of the hip","volume":"36","author":"Boddapati","year":"2021","journal-title":"J. Arthroplasty"},{"key":"10.1016\/j.suronc.2023.102014_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvir.2022.100802","article-title":"Percutaneous fixation of impending fracture of the hip","volume":"25","author":"Roux","year":"2022","journal-title":"Tech. Vasc. Intervent. Radiol."},{"key":"10.1016\/j.suronc.2023.102014_bib19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.21873\/anticanres.15550","article-title":"Outcomes of intramedullary nail fixation for metastatic disease: impending and pathologic fractures","volume":"42","author":"Owen","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.suronc.2023.102014_bib20","first-page":"302","article-title":"Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome","volume":"52","author":"Ristevski","year":"2009","journal-title":"Can. J. Surg."},{"key":"10.1016\/j.suronc.2023.102014_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2106\/JBJS.16.00023","article-title":"Thromboembolic disease in patients with metastatic femoral lesions: a comparison between prophylactic fixation and fracture fixation","volume":"99","author":"Aneja","year":"2017","journal-title":"JBJS"},{"key":"10.1016\/j.suronc.2023.102014_bib22","first-page":"1392","article-title":"Molecular pathways and therapeutic targets in lung cancer","volume":"5","author":"Shtivelman","year":"2014"},{"key":"10.1016\/j.suronc.2023.102014_bib23","first-page":"497","article-title":"EGFR-mutated lung cancer: a paradigm of molecular oncology","volume":"1","author":"Zhang","year":"2010"},{"key":"10.1016\/j.suronc.2023.102014_bib24","article-title":"A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives","volume":"6","author":"Russo","year":"2015"},{"key":"10.1016\/j.suronc.2023.102014_bib25","first-page":"3497","article-title":"Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid","volume":"21","author":"Von Moos","year":"2013"},{"key":"10.1016\/j.suronc.2023.102014_bib26","first-page":"447","article-title":"Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016"},{"key":"10.1016\/j.suronc.2023.102014_bib27","first-page":"2","article-title":"Meta-analysis of clinical trials to assess denosumab over zoledronic acid in bone metastasis","volume":"43","author":"Chen","year":"2021"},{"key":"10.1016\/j.suronc.2023.102014_bib28","first-page":"137","article-title":"Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer","volume":"183","author":"Walter","year":"2020"},{"key":"10.1016\/j.suronc.2023.102014_bib29","first-page":"3246","article-title":"Elacestrant (oral selective estrogen receptor degrader) versus standard endocrine therapy for estrogen receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative advanced breast cancer: results from the randomized phase III EMERALD trial","volume":"40","author":"Bidard","year":"2022"},{"key":"10.1016\/j.suronc.2023.102014_bib30","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1186\/s40064-016-3572-8","article-title":"The burden of metastatic disease of the femur on the Medicare system","volume":"5","author":"Gendi","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.suronc.2023.102014_bib31","series-title":"Metastatic Bone Disease","first-page":"3","article-title":"Bone metastases: epidemiology and societal effect","author":"Ashford","year":"2016"},{"key":"10.1016\/j.suronc.2023.102014_bib32","first-page":"3748","article-title":"The surgical management of proximal femoral metastases","volume":"28","author":"Axelrod","year":"2021","journal-title":"A Narrative Rev"},{"key":"10.1016\/j.suronc.2023.102014_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/CORR.0000000000000803","article-title":"Is there an association between prophylactic femur stabilization and survival in patients with metastatic bone disease?","volume":"478","author":"Philipp","year":"2020","journal-title":"Clin Orthopaedics Related Res"},{"key":"10.1016\/j.suronc.2023.102014_bib34","first-page":"112","article-title":"Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur","volume":"23","author":"Selek","year":"2008"},{"key":"10.1016\/j.suronc.2023.102014_bib35","first-page":"412","article-title":"Intramedullary nailing for treatment of pathologic femoral fractures due to metastases","volume":"45","author":"Piccioli","year":"2014"},{"key":"10.1016\/j.suronc.2023.102014_bib36","first-page":"1","article-title":"Intramedullary nailing has sufficient durability for metastatic femoral fractures","volume":"14","author":"Tanaka","year":"2016"},{"key":"10.1016\/j.suronc.2023.102014_bib37","first-page":"184","article-title":"Management of subtrochanteric femoral fractures and metastases using long proximal femoral nail","volume":"35","author":"Ramakrishnan","year":"2004"},{"key":"10.1016\/j.suronc.2023.102014_bib38","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.10530","article-title":"The influence of alignment on risk of knee osteoarthritis progression according to baseline stage of disease","volume":"46","author":"Cerejo","year":"2002","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.suronc.2023.102014_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/230949900701500309","article-title":"Intramedullary nailing for pathological femoral fractures","volume":"15","author":"Sharma","year":"2007","journal-title":"J Orthopaedic Surg"},{"key":"10.1016\/j.suronc.2023.102014_bib40","first-page":"920","article-title":"Endoprosthetic treatment is more durable for pathologic proximal femur fractures","volume":"470","author":"Steensma","year":"2012"},{"key":"10.1016\/j.suronc.2023.102014_bib41","first-page":"132","article-title":"Insight opinion to surgically treated metastatic bone disease: scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis","volume":"22","author":"Ratasvuori","year":"2013"},{"key":"10.1016\/j.suronc.2023.102014_bib42","first-page":"1684","article-title":"Patient survival after hip arthroplasty for metastatic disease of the hip","volume":"86","author":"Schneiderbauer","year":"2004"},{"key":"10.1016\/j.suronc.2023.102014_bib43","first-page":"483","article-title":"Complications after surgical management of proximal femoral metastasis: a retrospective study of 417 patients","volume":"24","author":"Janssen","year":"2016"},{"key":"10.1016\/j.suronc.2023.102014_bib44","first-page":"1653","article-title":"Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail?","volume":"87","author":"Wedin","year":"2005"},{"key":"10.1016\/j.suronc.2023.102014_bib45","series-title":"Orthopaedic Management of Metastatic Bone Disease","author":"Harrington","year":"1988"},{"key":"10.1016\/j.suronc.2023.102014_bib46","first-page":"1158","article-title":"Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients","volume":"66","author":"Sarahrudi","year":"2009"},{"key":"10.1016\/j.suronc.2023.102014_bib47","first-page":"808","article-title":"External validation of PATHFx version 3.0 in patients treated surgically and nonsurgically for symptomatic skeletal metastases","volume":"478","author":"Anderson","year":"2020"},{"key":"10.1016\/j.suronc.2023.102014_bib48","first-page":"29","article-title":"Unreamed intramedullary nailing for pathological femoral fractures: good results in 30 cases","volume":"70","author":"Giannoudis","year":"1999"},{"key":"10.1016\/j.suronc.2023.102014_bib49","first-page":"334","article-title":"Uncemented total hip arthroplasty in the elderly","volume":"23","author":"Konstantoulakis","year":"1999"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740423001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740423001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:24:37Z","timestamp":1760757877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740423001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":49,"alternative-id":["S0960740423001147"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2023.102014","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Femoral metastatic pathological fractures, impending and actual fractures \u2013 A patient survival study","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2023.102014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102014"}}